(Reuters) - On April 5, Sanofi-Aventis filed suit in the U.S. District Court of New Jersey to prevent Barr from proceeding with the commercialization of its product, Barr said in a statement.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment